Lo YMD - Search Results

1

Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma.

Ma B, Hui EP, King A, Leung SF, Kam MK, Mo F, Li L, Wang K, Loong H, Wong A, Chan CM, Chan KCA, Wong SCC, Lo YMD, Chan AT. Ma B, et al. Among authors: lo ymd. Br J Cancer. 2018 Apr;118(8):1051-1055. doi: 10.1038/s41416-018-0026-9. Epub 2018 Mar 20. Br J Cancer. 2018. PMID: 29555989 Free PMC article. Clinical Trial.

2

Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.

Lei KI, Chan LY, Chan WY, Johnson PJ, Lo YM. Lei KI, et al. Clin Cancer Res. 2002 Jan;8(1):29-34. Clin Cancer Res. 2002. PMID: 11801537

3

Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals.

Ng EK, Tsui NB, Lam NY, Chiu RW, Yu SC, Wong SC, Lo ES, Rainer TH, Johnson PJ, Lo YM. Ng EK, et al. Clin Chem. 2002 Aug;48(8):1212-7. Clin Chem. 2002. PMID: 12142376

4

Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma.

Chan AT, Lo YM, Zee B, Chan LY, Ma BB, Leung SF, Mo F, Lai M, Ho S, Huang DP, Johnson PJ. Chan AT, et al. J Natl Cancer Inst. 2002 Nov 6;94(21):1614-9. doi: 10.1093/jnci/94.21.1614. J Natl Cancer Inst. 2002. PMID: 12419787

5

Fetal DNA clearance from maternal plasma is impaired in preeclampsia.

Lau TW, Leung TN, Chan LY, Lau TK, Chan KC, Tam WH, Lo YM. Lau TW, et al. Clin Chem. 2002 Dec;48(12):2141-6. Clin Chem. 2002. PMID: 12446469

6

Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma.

Chan KC, Lo YM. Chan KC, et al. Semin Cancer Biol. 2002 Dec;12(6):489-96. doi: 10.1016/s1044579x02000913. Semin Cancer Biol. 2002. PMID: 12450734 Review.

7

Serial analysis of fetal DNA concentrations in maternal plasma in late pregnancy.

Chan LY, Leung TN, Chan KC, Tai HL, Lau TK, Wong EM, Lo YM. Chan LY, et al. Clin Chem. 2003 Apr;49(4):678-80. doi: 10.1373/49.4.678. Clin Chem. 2003. PMID: 12651830 No abstract available.

8

Quantitative analysis of pleural fluid cell-free DNA as a tool for the classification of pleural effusions.

Chan MH, Chow KM, Chan AT, Leung CB, Chan LY, Chow KC, Lam CW, Lo YM. Chan MH, et al. Clin Chem. 2003 May;49(5):740-5. doi: 10.1373/49.5.740. Clin Chem. 2003. PMID: 12709364

9

Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients.

Chan KC, Zhang J, Chan AT, Lei KI, Leung SF, Chan LY, Chow KC, Lo YM. Chan KC, et al. Cancer Res. 2003 May 1;63(9):2028-32. Cancer Res. 2003. PMID: 12727814

10

Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.

Leung SF, Chan AT, Zee B, Ma B, Chan LY, Johnson PJ, Lo YM. Leung SF, et al. Cancer. 2003 Jul 15;98(2):288-91. doi: 10.1002/cncr.11496. Cancer. 2003. PMID: 12872347 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters